You are here

Article Text

Article menu
Download PDFPDF
Research Article
Somatostatin therapy of acute experimental pancreatitis.
  1. P G Lankisch,
  2. H Koop,
  3. K Winckler,
  4. U R Fölsch,
  5. W Creutzfeldt

    Abstract

    Because somatostatin (SRIF) reduces exocrine pancreatic secretion, its effect on acute pancreatitis was investigated in rats. Linear SRIF reduced serum amylase and lipase but had no effect on pancreatic necrosis, oedema, leucocyte infiltration, and enzyme content. The mortality rate was not reduced. These results do not recommend the use of SRIF in the treatment of acute pancreatitis.

    https://doi.org/10.1136/gut.18.9.713

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.